PHASE I DOSE‐ESCALATION STUDY OF VENETOCLAX PLUS BEAM FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR CHEMORESISTANT, RELAPSED/REFRACTORY, OR HIGH‐RISK NON‐HODGKIN'S LYMPHOMA (NHL); PRELIMINARY RESULTS

Saved in:
Bibliographic Details
Published in:Hematological oncology 2019-06, Vol.37 (S2), p.528-529
Main Authors: Maakaron, J., Zhao, Q., Puto, M., Von Derau, R., Robinson, J., Brammer, J., Penza, S., Baiocchi, R., Christian, B., Maddocks, K., Saad, A., Wall, S., Benson, D., Efebera, Y., Rosko, A., Ayyappan, S., Grieselhuber, N., Vasu, S., Larkin, K., Epperla, N., Devarakonda, S., Choe, H., Chaudhry, M., Blaser, B., Blachly, J., Bhatnagar, B., Alinari, L., Mims, A., Jaglowski, S., William, B.M.
Format: Article
Language:English
Subjects:
Autografts
Lymphoma
Non-Hodgkin's lymphoma
Stem cells
Transplants & implants
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.213_2631